
SATURN V CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IVVD | 10.95M | $14.23M |
![]() | XFOR | 6.46M | $26.67M |
![]() | AMLX | 4.35M | $60.46M |
![]() | OVID | 4.17M | $9.25M |
![]() | IKT | 3.86M | $6.49M |
![]() | IMMX | 3.69M | $33.65M |
![]() | ALMS | 3.20M | $70.54M |
![]() | CADL | 2.90M | $14.19M |
![]() | PHVS | 1.20M | $33.94M |
![]() | DYN | 967K | $17.52M |
![]() | PCVX | 825K | $47.91M |
![]() | ZURA | 740K | $4.40M |
![]() | COGT | 627K | $24.12M |
![]() | ABVX | 543K | $60.43M |
![]() | OCS | 517K | $13.74M |
![]() | IRON | 450K | $28.77M |
![]() | MNPR | 346K | $18.94M |
![]() | CELC | 282K | $32.18M |
![]() | JAZZ | 163K | $30.81M |
![]() | ANRO | 89K | $2.00M |

Invivyd, Inc.
IVVD
Shares Held
10.95M
Value
$14.23M

X4 Pharmaceuticals, Inc.
XFOR
Shares Held
6.46M
Value
$26.67M

Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
4.35M
Value
$60.46M

Ovid Therapeutics Inc.
OVID
Shares Held
4.17M
Value
$9.25M

Inhibikase Therapeutics, Inc.
IKT
Shares Held
3.86M
Value
$6.49M

Immix Biopharma, Inc.
IMMX
Shares Held
3.69M
Value
$33.65M

Alumis Inc. Common Stock
ALMS
Shares Held
3.20M
Value
$70.54M

Candel Therapeutics, Inc.
CADL
Shares Held
2.90M
Value
$14.19M

Pharvaris N.V.
PHVS
Shares Held
1.20M
Value
$33.94M

Dyne Therapeutics, Inc.
DYN
Shares Held
967K
Value
$17.52M

Vaxcyte, Inc.
PCVX
Shares Held
825K
Value
$47.91M

Zura Bio Limited
ZURA
Shares Held
740K
Value
$4.40M

Cogent Biosciences, Inc.
COGT
Shares Held
627K
Value
$24.12M

Abivax S.A.
ABVX
Shares Held
543K
Value
$60.43M

Oculis Holding AG
OCS
Shares Held
517K
Value
$13.74M

Disc Medicine, Inc.
IRON
Shares Held
450K
Value
$28.77M

Monopar Therapeutics Inc.
MNPR
Shares Held
346K
Value
$18.94M

Celcuity Inc.
CELC
Shares Held
282K
Value
$32.18M

Jazz Pharmaceuticals plc
JAZZ
Shares Held
163K
Value
$30.81M

Alto Neuroscience, Inc.
ANRO
Shares Held
89K
Value
$2.00M
